š—”š—²š˜„š˜€ š—¦š˜‚š—ŗš—ŗš—®š—æš˜†
• A study published in The Lancet Regional Health - Southeast Asia journal found that a higher dose of the COVID-19 drug, dexamethasone, may have less beneficial effects for patients in India compared to those in Europe.
• The study looked at how well a strong dose of dexamethasone worked for COVID-19 patients and found that the bigger dose did not seem to be as effective for Indian patients.
• The study also emphasized the importance of considering patient differences and health systems when assessing the efficacy of treatments.